SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells

PURPOSE: We previously demonstrated an association between decreased SMAD4 expression and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to further elucidate the clinical relevance of SMAD4 loss in HNSCC. EXPERIMENTAL DESIGN: SMAD4 expression was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Ozawa, Hiroyuki, Ranaweera, Ruchira, Izumchenko, Evgeny, Makarev, Eugene, Zhavoronkov, Alex, Fertig, Elana J., Howard, Jason D., Markovic, Ana, Bedi, Atul, Ravi, Rajani, Perez, Jimena, Le, Quynh-Thu, Kong, Christina S., Jordan, Richard C., Wang, Hao, Kang, Hyunseok, Quon, Harry, Sidransky, David, Chung, Christine H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078415/
https://ncbi.nlm.nih.gov/pubmed/28522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1686
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados